buyWeak
Redmile Group, LLC bought $669k of FATE
director, owner at FATE THERAPEUTICS INC. 397,964 shares at an average of $1.68, traded Dec 20, 2024, filed Dec 26, 2024.
Conviction score
35Value
$669k
397,964 shares
Holdings after
12,884,277
+3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-131794, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | JOther Common Stockindirect: See Footnote | -1,084,936 | $1.68 | $1.8M | 11,743,010 | Dec 26, 2024 |
| Dec 20, 2024 | JOther Common Stockindirect: See Footnote | +1,084,936 | $1.68 | $1.8M | 12,827,946 | Dec 26, 2024 |
| Dec 20, 2024 | SOpen-market sale Common Stockindirect: See Footnote | -341,633 | $1.68 | $574k | 12,486,313 | Dec 26, 2024 |
| Dec 20, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +397,964 | $1.68 | $669k | 12,884,277 | Dec 26, 2024 |
| Dec 20, 2024 | JOther Class A Convertible Preferred Stockderivativeindirect: See Footnote | -116,261 | $8.40 | $977k | 2,638,825 | Dec 26, 2024 |
| Dec 20, 2024 | JOther Class A Convertible Preferred Stockderivativeindirect: See Footnote | +116,261 | $8.40 | $977k | 2,755,086 | Dec 26, 2024 |
| Dec 20, 2024 | JOther Cash-settled Swapsderivativeindirect: See Footnote | -56,331 | $1.68 | $95k | 502,769 | Dec 26, 2024 |
Related signals
Other insiders at FATE THERAPEUTICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 30Weak | sell 3 | FATE FATE THERAPEUTICS INC | Bressi Jerome Charles See Remarks | $9,269 | 5,980 | |
| 40Moderate | sell 3 | FATE FATE THERAPEUTICS INC | Valamehr Bahram President and CEO | $13k | 8,705 | |
| 30Weak | sell 3 | FATE FATE THERAPEUTICS INC | TAHL CINDY See Remarks | $8,764 | 5,654 | |
| 34Weak | sell | FATE FATE THERAPEUTICS INC | Redmile Group, LLC director, owner | $574k | 341,633 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.